| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970004 | The Journal of Heart and Lung Transplantation | 2015 | 17 Pages |
Abstract
A significant proportion of patients on the HT waiting list will have VA. WCD use in our study showed high compliance and efficacy and a low complication rate, suggesting that the WCD is a reasonable bridge therapy for preventing SCD in patients awaiting HT.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Madalina MD, PhD, Chingping MD, MSHCPM, Vini MD, Negar MD, Jaffri BS, Steven J. MD, Ranjan K. MD, MPH,